Antimicrobial and antimotility agent use in persons with shiga toxin-producing escherichia coli o157 infection in foodnet sites

Clinical Infectious Diseases

Volumn 52, Issue 9, 2011, Pages 1130-1132

  Nelson, Jennifer M ^a   Griffin, Patricia M ^b   Jones, Timothy F ^c   Smith, Kirk E ^d   Scallan, Elaine ^e  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c TENNESSEE DEPARTMENT OF HEALTH   (United States)

^d MINNESOTA DEPARTMENT OF HEALTH   (United States)

^e Global Health and Health Disparities   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ATROPINE; BETA LACTAM ANTIBIOTIC; COTRIMOXAZOLE; DICYCLOVERINE; DIPHENOXYLATE; HYOSCYAMINE; LOPERAMIDE; MACROLIDE; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SHIGA TOXIN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG USE; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; FECES CULTURE; FOOD POISONING; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFECTIOUS DIARRHEA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; REHYDRATION; RISK FACTOR; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIPHENOXYLATE; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; HEMOLYTIC-UREMIC SYNDROME; HUMANS; LOPERAMIDE; PARASYMPATHOLYTICS; PHYSICIAN'S PRACTICE PATTERNS; POPULATION SURVEILLANCE; SHIGA TOXINS; YOUNG ADULT;

EID: 79953884103     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir087     Document Type: Article

References (19)

1. Centers for Disease Control and Prevention. Preliminary FoodNet Data on the incidence of infection with pathogens transmitted commonly through food-10 States, 2008. MMWR Morb Mortal Wkly Rep 2009; 58:333-7.
2. Gould LH, Demma L, Jones TF, et al. Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clin Infect Dis 2009; 49:1480-5.
3. Molbak K, Mead PS, Griffin PM. Antimicrobial therapy in patients with Escherichia coli O157:H7 infection. JAMA 2002; 288:1014-6. (Pubitemid 34920469)
4. Wong CS, Jelacic S, Habeeb RL, et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000; 342:1930-6. (Pubitemid 30419087)
5. Dundas S, Todd WT, Stewart AI, et al. The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis 2001; 33:923-31. (Pubitemid 32907091)
6. Safdar N, Said A, Gangnon RE, et al. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. JAMA 2002; 288:996-1001. (Pubitemid 34920465)
7. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001; 32:331-51. (Pubitemid 32173618)
8. Slutsker L, Ries AA, Maloney K, et al. A nationwide casecontrol study of Escherichia coli O157:H7 infection in the United States. J Infect Dis 1998; 177:962-6. (Pubitemid 28155149)
9. Thielman NM, Guerrant RL. Clinical practice. Acute infectious diarrhea. N Engl J Med 2004; 350:38-47. (Pubitemid 38032182)
10. Kassenborg HD, Hedberg CW, Hoekstra M, et al. Farm visits and undercooked hamburgers as major risk factors for sporadic Escherichia coli O157:H7 infection: data from a casecontrol study in 5 FoodNet sites. Clin Infect Dis 2004; 38(Suppl 3);S271-8. (Pubitemid 38553334)
11. Voetsch AC, Kennedy MH, Keene WE, et al. Risk factors for sporadic Shiga toxin-producing Escherichia coli O157 infections in FoodNet sites, 1999-2000. Epidemiol Infect 2006:1-8.
12. Carpenter LR, Pont SJ, Cooper WO, et al. Stool cultures and antimicrobial prescriptions related to infectious diarrhea. J Infect Dis 2008; 197:1709-12. (Pubitemid 351919635)
13. Oldfield EC 3rd, Wallace MR. The role of antibiotics in the treatment of infectious diarrhea. Gastroenterol Clin North Am 2001; 30:817-36. (Pubitemid 32880454)
14. Devasia RA, Varma JK, Whichard J, et al. Antimicrobial use and outcomes in patients with multidrug-resistant and pansusceptible Salmonella Newport infections, 2002-2003. Microb Drug Resist 2005; 11:371-7. (Pubitemid 43099775)
15. Fullerton KE, Ingram LA, Jones TF, et al. Sporadic campylobacter infection in infants: a population-based surveillance casecontrol study. Pediatr Infect Dis J 2007; 26:19-24. (Pubitemid 46045746)
16. Jones TF, Ingram LA, Fullerton KE, et al. A casecontrol study of the epidemiology of sporadic Salmonella infection in infants. Pediatrics 2006; 118:2380-7. (Pubitemid 46397577)
17. Bell BP, Griffin PM, Lozano P, et al. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 1997; 100:E12.
18. DuPont HL, Hornick RB. Adverse effect of lomotil therapy in shigel-losis. JAMA 1973; 226:1525-8.
19. Scallan E. Activities, achievements, and lessons learned during the first 10 years of the Foodborne Diseases Active Surveillance Network: 1996- 2005. Clin Infect Dis 2007; 44:718-25.